STRATA Skin Sciences Preliminary Q2 2024 Revenue Guidance Of $8M-$8.4M Vs $7.42M Est.

7/11/24 8:04:25 AM ET

Medical/Dental Instruments

Health Care

Get the next $SSKN alert in real time by email

STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces preliminary total revenue in the range of $8.0 million - $8.4 million for the second quarter of 2024. Consistent with the Company's stated plans of realigning its devices and removing them from underperforming account, the domestic installed base of XTRAC® devices declined from 907 at the end of the first quarter of 2024 to 881 at the end of the second quarter of 2024. The domestic installed base of TheraClear®X devices continued to grow, rising from 104 at the end of the first quarter of 2024 to 117 at the end of the second quarter of 2024. Cash, cash equivalents, and restricted cash totaled $6.8 million at the end of the second quarter of 2024.

Get the next $SSKN alert in real time by email

STRATA Skin Sciences Preliminary Q2 2024 Revenue Guidance Of $8M-$8.4M Vs $7.42M Est.

Chat with this insight

Recent Analyst Ratings for $SSKN

$SSKN Market Insights

Live Market Insights

STRATA Skin Sciences Receives Approval For The XTRAC Momentum 1.0 Device In Japan

STRATA Skin Sciences' TheraClearX Acne Therapy System Found Safe And Effective In Study Published In The July 11, 2024 Issue Of The Journal Of Cosmetic And Laser Therapy

STRATA Skin Sciences Preliminary Q2 2024 Revenue Guidance Of $8M-$8.4M Vs $7.42M Est.

$SSKN SEC Filings

Strata Skin Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

Strata Skin Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Strata Skin Sciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

$SSKN Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Geiger Uri bought $723,999 worth of shares (230,573 units at $3.14) (SEC Form 4)

Large owner Accelmed Partners, L.P. bought $723,999 worth of shares (230,573 units at $3.14), increasing direct ownership by 19% to 1,441,835 units (SEC Form 4)

Chief Executive Officer Rafaeli Dolev bought $59,974 worth of shares (19,100 units at $3.14), increasing direct ownership by 15% to 143,156 units (SEC Form 4)

$SSKN Leadership Updates

Live Leadership Updates

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

STRATA Skin Sciences Appoints Dr. Uri Geiger to Chairman of its Board of Directors

STRATA Skin Sciences Appoints Patricia S. Walker, M.D., Ph.D. to its Board of Directors

$SSKN Press Releases

Fastest customizable press release news feed in the world

STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

STRATA Skin Sciences Announces Favorable Court Order in Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group

STRATA Skin Sciences to Report Third Quarter 2024 Financial Results on November 13, 2024 and Provide Corporate Update

$SSKN Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 3 filed by new insider Gillings John T

SEC Form 4 filed by Director Allgeier Christina L

SEC Form 3 filed by new insider Allgeier Christina L

$SSKN Large Ownership Changes

This live feed shows all institutional transactions in real time.

$SSKN Financials

Live finance-specific insights

Amendment: SEC Form SC 13G/A filed by Strata Skin Sciences Inc.

Amendment: SEC Form SC 13D/A filed by Strata Skin Sciences Inc.

SEC Form SC 13G/A filed by Strata Skin Sciences Inc. (Amendment)

STRATA Skin Sciences to Report Third Quarter 2024 Financial Results on November 13, 2024 and Provide Corporate Update

STRATA Skin Sciences to Report Second Quarter 2024 Financial Results on August 14, 2024 and Provide Corporate Update

STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update

Recent Analyst Ratings for
$SSKN

$SSKN
Market Insights

$SSKN
SEC Filings

$SSKN
Insider Purchases

$SSKN
Leadership Updates

$SSKN
Press Releases

$SSKN
Insider Trading

$SSKN
Large Ownership Changes

$SSKN
Financials